We treated human lung cancer cells A549 and H1299 with 50 mM dichloroacetate (DCA).
DCA decreased lactate production and attenuated aerobic glycolysis.
DCA slowed cell growth and altered cell cycle distribution.
DCA significantly increased single and fractionated X-ray-induced cell killing.
DCA inhibited X-ray-induced DNA double-strand break repair.